Standard BioTools Inc.

DB:FLB Stock Report

Market Cap: €722.7m

Standard BioTools Balance Sheet Health

Financial Health criteria checks 6/6

Standard BioTools has a total shareholder equity of $489.3M and total debt of $55.2M, which brings its debt-to-equity ratio to 11.3%. Its total assets and total liabilities are $681.5M and $192.2M respectively.

Key information

11.3%

Debt to equity ratio

US$55.21m

Debt

Interest coverage ration/a
CashUS$366.33m
EquityUS$489.33m
Total liabilitiesUS$192.21m
Total assetsUS$681.54m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: FLB's short term assets ($453.6M) exceed its short term liabilities ($120.6M).

Long Term Liabilities: FLB's short term assets ($453.6M) exceed its long term liabilities ($71.6M).

Debt to Equity History and Analysis

Debt Level: FLB has more cash than its total debt.

Reducing Debt: FLB's debt to equity ratio has reduced from 30.7% to 11.3% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: FLB has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: FLB has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 26.9% each year

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y